Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 31, 2009
Grant Date -
Aug 28, 2003
app pub date -
Mar 11, 2002
filing date -
Mar 9, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
. Convenient restriction sites allow for the facile introduction of additional amino-terminal domains. Methods for treating patients using fusion proteins are also disclosed. The HCH2 polymers described here represent a new strategy in the design of recombinant proteins for the therapeutic targeting of FcγR in autoimmune disorders.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully